Valuation Update With 7 Day Price Move • Jul 30
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to ₩3,890, the stock trades at a trailing P/E ratio of 16.9x. Average trailing P/E is 12x in the Medical Equipment industry in South Korea. Total loss to shareholders of 39% over the past year. Valuation Update With 7 Day Price Move • Jun 26
Investor sentiment deteriorates as stock falls 34% After last week's 34% share price decline to ₩4,525, the stock trades at a trailing P/E ratio of 19.6x. Average trailing P/E is 15x in the Medical Equipment industry in South Korea. Total loss to shareholders of 40% over the past year. New Risk • Jun 23
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (79% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2025 fiscal period end). Share price has been volatile over the past 3 months (12% average weekly change). Market cap is less than US$100m (₩81.5b market cap, or US$53.1m). Valuation Update With 7 Day Price Move • Jun 08
Investor sentiment deteriorates as stock falls 21% After last week's 21% share price decline to ₩5,220, the stock trades at a trailing P/E ratio of 22.6x. Average trailing P/E is 13x in the Medical Equipment industry in South Korea. Total loss to shareholders of 25% over the past year. New Risk • Jun 02
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (79% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2025 fiscal period end). Market cap is less than US$100m (₩87.5b market cap, or US$57.7m). Valuation Update With 7 Day Price Move • May 13
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩9,900, the stock trades at a trailing P/E ratio of 42.3x. Average trailing P/E is 20x in the Medical Equipment industry in South Korea. Total returns to shareholders of 36% over the past year. Valuation Update With 7 Day Price Move • Mar 04
Investor sentiment deteriorates as stock falls 25% After last week's 25% share price decline to ₩7,510, the stock trades at a trailing P/E ratio of 32.1x. Average trailing P/E is 19x in the Medical Equipment industry in South Korea. Total returns to shareholders of 1.2% over the past year. Valuation Update With 7 Day Price Move • Jan 08
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₩10,160, the stock trades at a trailing P/E ratio of 43.4x. Average trailing P/E is 19x in the Medical Equipment industry in South Korea. Total returns to shareholders of 60% over the past year. New Risk • Jan 06
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩142.5b (US$98.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). High level of non-cash earnings (79% accrual ratio). Minor Risk Market cap is less than US$100m (₩142.5b market cap, or US$98.5m). Upcoming Dividend • Dec 22
Upcoming dividend of ₩50.00 per share Eligible shareholders must have bought the stock before 29 December 2025. Payment date: 27 April 2026. Trailing yield: 0.2%. Lower than top quartile of South Korean dividend payers (3.6%). Lower than average of industry peers (1.1%). Valuation Update With 7 Day Price Move • Nov 26
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to ₩12,160, the stock trades at a trailing P/E ratio of 51.4x. Average trailing P/E is 19x in the Medical Equipment industry in South Korea. Total returns to shareholders of 155% over the past year. Valuation Update With 7 Day Price Move • Nov 12
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₩12,780, the stock trades at a trailing P/E ratio of 48.9x. Average trailing P/E is 19x in the Medical Equipment industry in South Korea. Total returns to shareholders of 169% over the past year. 공고 • Nov 07
P&S Robotics Co., Ltd. announces Annual dividend, payable on April 27, 2026 P&S Robotics Co., Ltd. announced Annual dividend of KRW 50.0000 per share payable on April 27, 2026, ex-date on December 29, 2025 and record date on December 31, 2025. Valuation Update With 7 Day Price Move • Oct 28
Investor sentiment improves as stock rises 31% After last week's 31% share price gain to ₩21,300, the stock trades at a trailing P/E ratio of 40.1x. Average trailing P/E is 21x in the Medical Equipment industry in South Korea. Total returns to shareholders of 86% over the past year. Valuation Update With 7 Day Price Move • Oct 15
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩16,880, the stock trades at a trailing P/E ratio of 31.8x. Average trailing P/E is 21x in the Medical Equipment industry in South Korea. Total returns to shareholders of 36% over the past year. 공고 • Feb 14
P&S Mechanics Co Ltd, Annual General Meeting, Mar 28, 2025 P&S Mechanics Co Ltd, Annual General Meeting, Mar 28, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 70, seonyu-ro, yeongdeungpo-gu, seoul South Korea New Risk • Feb 13
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risk Market cap is less than US$100m (₩89.0b market cap, or US$61.5m). 
